Our team
Sunil Patel
Senior Vice President & Head, Business Development & Licensing
“We are strongly committed to partnership success and recognize that the greatest achievements are not reached alone. They are the result of teamwork. Reach out to us to discuss how we can work together to save and improve lives.”
Christopher Mortko
Head, Headquarters Search and Evaluation
Headquarters Search and Evaluation
Stephen de Laszlo
Infectious Diseases & Vaccines
Kim Folander
Enabling Technologies
Jose Freire
Immunology and Respiratory
Ronald Kim
Cardiometabolic Diseases, Renal, Ophthalmology
Paige Lacatena
Neuroscience
Andrew Latham
Enabling Technologies
Patrick Moriarty
Oncology
Agam Sheth
Enabling Technologies
Joseph Simeone
Oncology
Elizabeth Naldi-Jacob
Head, Headquarters Transactions
Headquarters Transactions
Anusha Dwivedi
Transactions
Ken Johnson
Transactions
Pam Marini
Transactions
Michael Miller
Transactions
Shane Schwartz
Transactions
Shari Wahl
Transactions
Lizabeth Leveille
Head, Boston and European Sites
Boston Site
Albert Hsia
Oncology, Immunology
Blair Lapointe
Transactions
Kathryn McAllister
Cardiometabolic Diseases, Renal, Ophthalmology, and Neuroscience
Mark Stencik
Transactions
Christopher Tan
Infectious Diseases & Vaccines
European Site
Khatereh Ahmadi
Head, Europe S&E
Oncology
Michel de Baar
Cardiometabolic Diseases, Renal, Ophthalmology, Immunology, Infectious Disease and Vaccines
Daniel Marshall
Oncology
Karen McGurk
Transactions
Richard Reschen
Neuroscience
Grace Han McMahon
Head, Pacific Site
Pacific Site
Michelle Booden
West Coast North America
Immunology, Respiratory, Infectious Diseases & Vaccines, Oncology
Russell DeKelver
West Coast North America
Oncology, Cardiometabolic Diseases
Bill Jakobowski
Transactions
Luna Ji
Asia Pacific
All Therapeutic Areas
Nikhil Mutyal
West Coast North America
Oncology, Neuroscience, Cardiometabolic Diseases, Renal, Ophthalmology
Koji Yashiro
Asia Pacific
All Therapeutic Areas
Peter Dudek
President, MRL Ventures Fund
MRL Ventures Fund
Olga Danilchanka
Principal